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Accepted 23 July 2016; Published online 30 July 2016AbstractObjective: To compare meta-analyses of diagnostic test accuracy using the MoseseLittenberg summary receiver operating character-
istic (SROC) approach with those of the hierarchical SROC (HSROC) model.
Study Design and Setting: Twenty-six data sets from existing test accuracy systematic reviews were reanalyzed with the Mo-
seseLittenberg model, using equal weighting (‘‘E-ML’’) and weighting by the inverse variance of the log DOR (‘‘W-ML’’), and with
the HSROC model. The diagnostic odds ratios (DORs) were estimated and covariates added to both models to estimate relative DORs
(RDORs) between subgroups. Models were compared by calculating the ratio of DORs, the ratio of RDORs, and P-values for detecting
asymmetry and effects of covariates on DOR.
Results: Compared to the HSROC model, the MoseseLittenberg model DOR estimates were a median of 22% (‘‘E-ML’’) and 47%
(‘‘W-ML’’) lower at Q*, and 7% and 42% lower at the central point in the data. Instances of the ML models giving estimates higher than
the HSROC model also occurred. Investigations of heterogeneity also differed; the MoseseLittenberg models on average estimating smaller
differences in RDOR.
Conclusions: MoseseLittenberg meta-analyses can generate lower estimates of test accuracy, and smaller differences in accuracy,
compared to mathematically superior hierarchical models. This has implications for the usefulness of meta-analyses using this approach.
We recommend meta-analysis of diagnostic test accuracy studies to be conducted using available hierarchical modelebased ap-
proaches.  2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
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There is a considerable body of systematic reviews and
meta-analyses of diagnostic test accuracy (DTA) in the public
domain [1,2]. Meta-analysis allows more precise estimation
of test accuracy, can provide a stronger comparison of the ac-
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licenses/by-nc-nd/4.0/).allows the inevitable variability between studies to be quanti-
fied and formally investigated, as and when there is sufficient
cause to suspect clinical or methodological variability [3,4].
The statistical pooling of test accuracy studies presents an
added level of complexity over and above that presented by
trials of therapeutic interventions. Accuracy is usually quanti-
fied by two related statistics (sensitivity and specificity) rather
than one, and meta-analysis must allow for the trade-off be-
tween the two. Approaches to DTA meta-analysis include
separate pooling of sensitivity and specificity estimates, the
linear regression approach to estimating summary receiver
operating characteristic (SROC) curves developed by Moses
and Littenberg (referred to here as MoseseLittenberg) [5,6],
and methods based on hierarchical models [7e11].ess article under the CC BY-NC-ND license (http://creativecommons.org/
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Key findings
 The MoseseLittenberg model for meta-analyzing
diagnostic test accuracy data on average generates
lower estimates of test accuracy in comparison to
the hierarchical summary ROC method for meta-
analysis.
 Substantial differences in results of investigations
of heterogeneity between models are produced,
both for estimates of the size of the effect and its
statistical significance.
What this adds to what was known?
 Our findings support and extend those of a previ-
ous empirical comparison of methods, further
raising concerns around the use of the results of
MoseseLittenberg meta-analyses in clinical
practice.
What is the implication and what should change
now?
 Evidence for current recommendations for the
preferential use of hierarchical models for diag-
nostic test meta-analyses is provided and should
further encourage their uptake.The theoretical limitations and advantages of the
different meta-analytical approaches are well documented
[12e14]. Although the MoseseLittenberg approach ac-
counts for the bivariate nature of the data and the inverse
correlation between sensitivity and specificity, it does not
appropriately model within- and between-study variability
to account for the uncertainty in the estimates, such that
confidence intervals and hypotheses tests from the model
are possibly invalid and summary operating points are hard
to estimate. The hierarchical models preserve the bivariate
nature of test accuracy data in terms of both model param-
eterization and interpretation, accounting for the correlation
between sensitivity and specificity; they appropriately
weight studies to account for within-study variability; and
use a random-effects approach to account for between-
study variability. They also allow estimation of the diag-
nostic odds ratio (DOR) and an average operating point
in terms of sensitivityespecificity pair, with associated con-
fidence and prediction regions.
The hierarchical models have been recommended for
DTA meta-analyses by the Cochrane Collaboration since
2007 [3]. However, the MoseseLittenberg model was used
in 43% of 760 meta-analyses of diagnostic or predictive ac-
curacy published between 1987 and 2009 and made up 86%
of all meta-analyses that used ROC approaches to synthesis[15]. A survey of 100 DTA meta-analyses published be-
tween September 2011 and January 2012 found that over
half continued to pool studies using either simple linear
regression-based SROC analysis or a univariate approach,
and not the preferred hierarchical models [16]. Three-
quarters of corresponding authors for 24 of the reviews us-
ing these ‘‘traditional’’ approaches believed the approach to
be ‘‘currently recommended’’ and 71% ‘‘believed that the
method yielded precise estimates’’ [16]. Meta-analyses un-
dertaken before this period are even more likely to have
used the mathematically inferior models [1,2].
Available empirical studies examining the impact of
choice of meta-analytic model on overall results have
reached conflicting conclusions, noting that hierarchical
models produce different results to simpler models [14]
or suggesting that conclusions may not differ [17,18]. None
of these studies considered possible effects on investiga-
tions of heterogeneity, such as looking at differences be-
tween tests or subgroups.
Given the widespread use of the MoseseLittenberg
meta-analysis model, there is a need to identify and quan-
tify any potential differences in estimates of test accuracy
and in investigations of sources of heterogeneity. The
complexity of the hierarchical models and their omission
from commonly used meta-analytical software programs
[19] further compounds the need to determine the degree
to which results might be affected by the choice of
approach. Our objective was to empirically compare the
MoseseLittenberg and hierarchical SROC (HSROC) ap-
proaches for the overall synthesis of DTA data and for
the investigation of sources of heterogeneity using a large
sample of systematic reviews.2. Methods
2.1. Identification, extraction, and analysis of
systematic review data
Existing test accuracy systematic reviews were identified
from the Database of Abstracts of Reviews of Effects, the
HTA database of the Cochrane Library, and the MEDION
database of systematic reviews. The cohort we analyzed
has been partially reported on previously [1] and includes
reviews published between 2000 and 2005 that presented
sufficient information to allow the construction of a 2 
2 contingency table comparing a test to a reference test
for at least five primary studies. Systematic reviews had
to include at least five studies and report at least one
study-level covariate. One reviewer assessed whether re-
views met these criteria. All subgroups in the data set con-
tained at least three studies.
Data on the experimental test and target disorder, the 2
 2 contingency table data, and data on any potential
spectrum-related sources of heterogeneity per study were
extracted independently by two reviewers. Disagreements
were resolved by consensus or referral to a third reviewer.
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Three alternative meta-analytical methods were consid-
ered, two formulations of the MoseseLittenberg model
with different study weighting, and the HSROC model.
The MoseseLittenberg model was fitted as originally
described [5,6]. The approach involves computing the logit-
transforms of sensitivity and the complement of specificity
and undertaking a linear regression of the difference between
them (D, or the log of the DOR) on the sum (S, a measure of
the proportion that are test positive, which is a proxy for test
threshold) to estimate an intercept parameter a and a slope
parameter b. A summary ROC curve is derived from the fitted
regression line. The test of the significance of the slope b is
used to determine whether there is evidence that the DOR
varies with the threshold parameter S, which implies that
the summary ROC curve has an asymmetric shape. Differ-
ences between subgroups in the log DOR can be investigated
by adding indicator variables as covariates. The parameter es-
timates for these are the log relative DOR (RDOR) comparing
the DOR between the subgroups. Inclusion of interactions be-
tween each covariate and the S parameter allows for different
shaped curves in each subgroup. We fitted models with and
without the interaction term. The regression intercept term es-
timates the log of the DOR at the Q* point, where sensitivity
is equal to specificity. We used the DOR value at this point in
accuracy comparisons, but as it may lie outside the results of
the observed studies, we also made comparisons of the DOR
estimated at the mean value of S which will be central to the
observed study results. We fitted the MoseseLittenberg
model giving equal weight to all studies (denoted ‘‘E-ML’’),
and weighting each study (denoted ‘‘W-ML’’) by the inverse
variance of the log DOR, in accordance with standard practice
[12]. A standard zero-cell correction (the addition of 0.5 to
every cell of a 2  2 table that contains at least one zero)
was used to avoid divide by zero errors.
Two versions of the hierarchical model are commonly
used for meta-analysis, the HSROC, and the bivariate
models, which have been shown to be mathematically
equivalent for single-test meta-analyses but to estimate
different parameters in investigations of heterogeneity
[14]. We chose the HSROC model for comparison with
the MoseseLittenberg models as both estimate RDOR in
heterogeneity investigations. We fitted the HSROC model
proposed by Rutter and Gatsonis [7,8] which is based on
a latent-scale logistic regression model [20,21]. The
HSROC model assumes that there is an underlying ROC
curve in each study with parameters a and b which charac-
terize the accuracy and asymmetry of the curve, in a similar
way to the a and b parameters in the linear regression
method of Moses and Littenberg. The parameter a esti-
mates log DOR at the Q* point and the significance of
the shape term b can be used to assess whether a symmetric
or asymmetric curve best fits to observed data. The model
has a third parameter q related to the proportion testpositivedits value is equivalent to the values of S/2 in
the MoseseLittenberg model. An average value for q is
estimated by the model, which allows identification of an
average operating point on the summary ROC curve central
to the observed data. The model is fitted at two levels. At
the first level, the proportions test positive in the reference
standard positive and negative groups are modeled
assuming they follow a binomial distribution, whereas at
the second level, variation between studies is modeled
assuming normal distributions for log DOR (a) and the pos-
itivity threshold parameter (q). To investigate heterogeneity
using the HSROC model, we fitted parallel SROC curves by
adding the covariate as a term to both the accuracy and
threshold parts of the model (such that the shape of the
SROC curves is determined using the whole set of studies).
We also fitted models that included a covariate as a third
term in the shape part of the model, to allow for variation
in differences in log DOR with threshold (allowing the
SROC curves to have different shapes; nonparallel).2.3. Comparison of meta-analytic models
We compared the performance of each MoseseLitten-
berg regression model with the results of the HSROC
model first for a simple meta-analysis by
(1) comparing DOR estimates by computing the ratio of
DOR from the MoseseLittenberg models compared
to the HSROC model at the central point in the data
(which is the equivalent of the average operating
point) and at the Q* value (the point where
sensitivity 5 specificity) (sample SROC curves from
each model shown in Box 1);
(2) comparing the detection of SROC curve asymmetry
between the MoseseLittenberg and HSROC models
by comparing P-values from Wald tests for the b term
in both models;
and then in investigations of heterogeneity contrasting
two subgroups,
(3) comparing estimates of the RDOR between the Mo-
seseLittenberg models and the HSROC model again
at the central point in the data and at Q*; and
(4) comparing the significance of the difference in DOR
between the models estimated by comparing P-values
from Wald tests for the log RDOR terms in both
models.
For the MoseseLittenberg model, we identified the cen-
tral point in the data as being at the mean value of S,
whereas for the HSROC model, we identified it as being
at the average operating point. For the comparison of sub-
groups, the RDOR can be less than or greater than one;
summary statistics were standardized to code the subgroups
such that the HSROC model always estimated an RDOR
greater than one.
Box 1 Sample SROC curves estimating using
MoseseLittenberg and HSROC models
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E-ML - Q*, average operating point
W-ML - Q*, average operating point
HSROC - average operating point
Abbreviations:Average operating point, DORpoint on
the SROC curve near to the center of the data usingmean
threshold; DOR, diagnostic odds ratio; E-ML, equal-
weight MoseseLittenberg; HSROC, hierarchical SROC;
Q*, DOR plotted at point on SROC curve where sensi-
tivity 5 specificity; SROC, summary receiver operating
characteristic; W-ML, MoseseLittenberg model
weighted by inverse variance of D.
Estimates using data from Scheidler et al. [22].
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between the models vary according to predefined aspects
of (1) magnitude of accuracy, (2) prevalence of zero cells,
(3) variation in threshold (based on values for ’S’ from
the MoseseLittenberg model).
The MoseseLittenberg analyses were performed in
STATA (StataCorp. 2013. Stata Statistical Software:
Release 13. College Station, TX: StataCorp LP.), and the
HSROC model was carried out using the PROC NLMIXED
command in SAS (SAS 2012, version 9.3; SAS Institute,
Cary, NC, USA).3. Results
3.1. Search results
The search identified 97 systematic reviews of test accu-
racy that presented sufficient data to complete 2  2 contin-
gency tables per study (Fig. 1). Information on at least onecovariate per study was presented in 29 reviews; however,
the HSROC model would not converge for three of the data
sets (occasional nonconvergence of the HSROC model,
particularly when there are few studies or when all studies
sit on one of the boundaries of SROC space is a recognized
phenomenon [23]). The comparisons between models are
therefore based on 26 data sets with a total of 55
spectrum-related covariate investigations (Supplementary
Table 1/Appendix at www.jclinepi.com). The HSROC
model could not be completed for nine covariate investiga-
tions (for one parallel curve SROC comparison, for four
nonparallel curve SROC comparisons, and for four covari-
ates using both parallel and nonparallel SROC curves),
either due to insufficient numbers of studies in at least
one of the subsets (for five of the nine covariates) or the
studies exhibited exceptionally high specificities with vary-
ing sensitivities. The median number of studies per review
was 16 (interquartile range [IQR] 12, 26); median sample
sizes of studies within each review ranged from 20 to 7,575.3.2. Comparison of diagnostic odds ratios
Estimates of the DOR from the MoseseLittenberg
methods were on average lower than those of the HSROC
model. Evaluated at the Q* point, the ‘‘E-ML’’ model esti-
mates of the DOR were a median of 22% lower (IQR 49%
lower to 2% higher) than those from the HSROC model,
whereas estimates from the ‘‘W-ML’’ model were a median
of 47% lower (IQR 76% lower to 28% lower). Differences
between models were smaller at the central threshold, but
still showed lower estimates for the MoseseLittenberg
models on average: 7% lower (IQR 32% lower to 4% high-
er) for ‘‘E-ML’’ and 42% lower (IQR 64% lower to 22%
lower) (Fig. 2A).
We categorized the meta-analyses according to their
DOR estimate from the HSROC model, the percentage of
studies with zero cells in 2  2 tables, and the range of
the threshold parameter S (Table 1). We noted greater
discrepancy between the methods when DORs were high
and with increasing percentages of zeros in 2  2 tables.
There was no clear relationship with the range of the
threshold parameter.
A wide range in results was observed for all model com-
parisons with both higher and lower estimates for Mo-
seseLittenberg models compared to HSROC models
(Fig. 2B). The five reviews responsible for most of the
extreme differences of DOR all had studies with very high
or close to perfect sensitivity [24,25] and/or specificity
[26e28] (Supplementary Fig. 1/Appendix at www.
jclinepi.com). The lack of data points near to Q* for these
reviews illustrates the unreliability of DORs estimated at
this point. The three data sets that produced extreme values
in all analyses were removed in a sensitivity analysis
[24,25,28]; differences in DOR estimates between Mo-
seseLittenberg and HSROC models remained for both
the ‘‘E-ML’’ and ‘‘W-ML’’ model comparisons (the overall
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Fig. 1. Flowchart of the review selection process. DARE, Database of Abstracts of Reviews of Effects.
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tively) (analysis not shown).3.3. Comparison of SROC curve shape
Fig. 3 shows broad but imperfect agreement between the
HSROC and MoseseLittenberg models in terms of tests of
the asymmetry of the SROC curve. Taking P ! 0.20 as
providing moderate to strong evidence of curve asymmetry,
SROC curve asymmetry was identified for 14 of the 26 data
sets using the HSROC model and 12 data sets for each of
the MoseseLittenberg models, with four and three reviews
showing disagreement for the ‘‘E-ML’’ and ‘‘W-ML’’
models, respectively.3.4. Comparison of estimates of RDOR in heterogeneity
investigations
Estimates of RDOR from heterogeneity investigations
were on average considerably lower when estimated by
the MoseseLittenberg models compared to the HSROC
model (Fig. 4). When estimated assuming parallel SROC
curves, RDOR values (median [IQR]) were 13% lower
[42% lower to 2% higher] for the ‘‘E-ML’’ model and
20% lower [46% lower to 5% higher] for the ‘‘W-ML’’
model. Including interaction terms to allow for nonparallel
SROC curves substantially increased both the average dif-
ference and the range of differences when evaluated both
at the Q* point and the central point.3.5. Comparison of the statistical significance of
sources of heterogeneity
Therewas poor agreement in the statistical significance of
the covariate investigations between MoseseLittenberg and
HSROC models with the P-value comparison points scat-
tered widely around the plots (Fig. 5). Disagreements ap-
peared worse for the models with nonparallel SROC curves.4. Discussion
We found that the simpler MoseseLittenberg models
produced lower estimates of DOR accuracy in comparison
with the more complex HSROC model, with median differ-
ences of 22% and 47% for unweighted and weighted
models at Q*, but with wide interquartile and overall ranges
for the differences. The greatest differences were observed
when the MoseseLittenberg model was weighted by the in-
verse variance of lnDOR, where the overall pooled DOR
was over 100, and where there were a high proportion of
zero cells; situations where the mathematical limitations
of MoseseLittenberg method creates misleading estimates.
The weighted MoseseLittenberg model uses the approx-
imate asymptotic standard error of the log DOR in allo-
cating study weights. We have previously shown (in the
context of funnel plots and tests for publication bias [29])
that the estimate of the standard error depends on the
lnDOR for values of DOR which are greater than one, lead-
ing funnel plot based tests such as the Begg and Egger tests
Fig. 2. Comparison of diagnostic odds ratios: ML models vs. HSROC model. (A) Box and whisker plots of ratio of DORs between models (HSROC
model estimate as reference). (B) Scatter plot of ratio of DORs between models (HSROC model estimate as reference). [ ] Denotes reference num-
ber for five reviews responsible for most of the extreme differences of DOR. DOR, diagnostic odds ratio; E-ML, equal-weight MoseseLittenberg;
HSROC, hierarchical SROC; max, maximum ratio of DORs; mean threshold, point on the SROC curve near to the center of the data; min, minimum
ratio of DORs; ML, MoseseLittenberg; p75, ratio of DORs at the 75th percentile; p50, ratio of DORs at the 50th percentile (median); p25, ratio of
DORs at the 25th percentile; Q*, point on SROC curve where sensitivity 5 specificity; SROC, summary receiver operating characteristic; W-ML,
MoseseLittenberg model weighted by inverse variance of D.
82 J. Dinnes et al. / Journal of Clinical Epidemiology 80 (2016) 77e87to overestimate the frequency of sample sizeerelated ef-
fects. The same relationship will affect the estimates of
standard errors for larger DOR, most often leading tooverestimation of standard errors at higher DOR, so that
an inverse varianceeweighted meta-analysis will lead to
underestimation of overall accuracy.
Table 1. Stratified comparison of diagnostic odds ratio (DOR)
estimates
Number of reviews
Comparison of DORs at mean thresholda
E-ML model vs.
HSROC model
W-ML model vs.
HSROC model
Median ROR [IQR] Median ROR [IQR]
Overall (n 5 26) 0.94 [0.68, 1.04] 0.59 [0.46, 0.78]
By size of DORb
DOR ! 35, n 5 9 0.99 [0.88, 1.16] 0.78 [0.60, 0.95]
DOR 35e100, n 5 10 1.00 [0.83, 1.05] 0.53 [0.42, 0.69]
DOR O 100, n 5 7 0.62 [0.30, 0.75] 0.42 [0.16, 0.59]
By % zero cellsc
!5%, n 5 10 1.01 [0.88, 1.05] 0.79 [0.53, 0.88]
5e10%, n 5 8 1.02 [0.94, 1.11] 0.63 [0.50, 0.74]
O10%, n 5 8 0.62 [0.30, 0.72] 0.42 [0.16, 0.63]
By range in ‘S’d
3 to !6, n 5 7 0.82 [0.48, 1.03] 0.75 [0.37, 0.79]
6 to !8, n 5 14 0.90 [0.68, 1.00] 0.53 [0.49, 0.75]
8, n 5 5 1.05 [0.99, 1.16] 0.57 [0.42, 0.73]
Abbreviations: E-ML, equal-weight MoseseLittenberg; W-ML,
weighted MoseseLittenberg; HSROC, hierarchical summary receiver
operating characteristic; ROR, ratio of DORs between models; median
ROR, ROR at the median; IQR, interquartile range in ROR from 25th
to 75th percentile; DOR, diagnostic odds ratio.
a Each MoseseLittenberg model is compared to the HSROC
model (denominator).
b The stratification by DOR is based on the HSROC overall pooled
estimate at mean threshold.
c Number of zero false-positive and false-negative cells as a per-
centage of the total number of cells per analysis.
d Based on values for ‘S’ from MoseseLittenberg model, where
S 5 logit(sensitivity) þ logit(1  specificity).
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model when sensitivities or specificities of 100% are
observed, also when the DOR is typically high. Adding0
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covariate investigations using the MoseseLittenberg
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findings have implications for meta-analyses that compare
tests as well as those which investigate the performance
of a single test in subgroups of studies.
Our results support and extend those of previous empir-
ical comparisons (one using a very large data set [15])
showing that SROC curves produced by the simpler Mo-
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by more rigorous methods but can in some cases diverge0
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84 J. Dinnes et al. / Journal of Clinical Epidemiology 80 (2016) 77e87[14,15]; neither of these comparisons compared average
operating points on the SROC curves however, and neither
compared the results of heterogeneity investigations.
Although our data set has shown that although in some cir-
cumstances there may be little difference on average be-
tween methods, the variability observed around the
average indicates the potential for large differences in test
accuracy, both in the overall result of the meta-analysis
and, perhaps more crucially, with the addition of covariates
to the models.
Our comparison of models is subject to a number of
limitations. Studies in our cohort were published between
2000 and 2005 with screening for inclusion conducted by
only one reviewer. However, given that our purpose was
to illustrate the potential effect across a number of data sets
rather than to reach a conclusion around the accuracy of a
given test, the potential for reviewer bias is limited.
Furthermore, the currency of the review cohort has no
impact on the statistical models used or external validity
of our results as there is no reason to consider that the re-
lationships between the methods would differ in more
recent studies. In terms of the statistical analyses, heteroge-
neity was common and the number of studies per meta-analysis was typical but low, with a median of 16 (range
7e46). These factors will have contributed to some of
the extreme results observed but many review authors will
nevertheless make the decision to meta-analyze studies in
these circumstances.
Furthermore, we focused on comparing DORs rather
than sensitivity and specificity estimates as the DOR is
the natural parameter of both the MoseseLittenberg and
HSROC models. This facilitated the comparison between
models to be illustrated with a single parameter; however,
the DOR is not as intuitive as other measures of test ac-
curacy. When we looked at summary estimates of sensi-
tivity and specificity at the average operating point and
at Q*, the ML model produced at least one estimate in
the order of 5% to 9% lower than the HSROC model in
12 of the 26 reviews, and 10% to 23% lower than the
HSROC model for 8 of the 26 reviews. Only one review
produced an estimate that was higher than that observed
from the HSROC model (for the E-ML estimate of sensi-
tivity). Although the differential effects on sensitivity and
specificity vary from case to case, the directional ‘‘bias’’
that we observed for the ML model in the DOR compar-
isons was supported by the comparisons of sensitivities
Fig. 5. Comparison of tests of statistical significance for difference in accuracy. E-ML, equal-weight MoseseLittenberg; HSROC, hierarchical
SROC; Q*, point on SROC curve where sensitivity 5 specificity; RDOR, relative diagnostic odds ratio; SROC, summary receiver operating charac-
teristic; W-ML, MoseseLittenberg model weighted by inverse variance of D.
85J. Dinnes et al. / Journal of Clinical Epidemiology 80 (2016) 77e87and specificities, with differences large enough to
mislead.
The strength of this study was the number of data sets
available for reanalysis. Further investigation, for example,
using simulated data, might be able to identify circum-
stances under which the MoseseLittenberg methods more
closely approximate those of the HSROC method.
Although there are more limited software options for fitting
hierarchical models than the MoseseLittenberg models,
requiring programs that fit mixed linear (or nonlinear for
the HSROC) logistic models, support for fitting these
models in SAS, STATA, R (https://www.r-project.org/),
and WinBUGS (http://www.mrc-bsu.cam.ac.uk/software/
bugs/), is now available such that they should be the
preferred approach [30,31]. Although convergenceproblems with the HSROC and bivariate model are encoun-
tered when there are few studies, fitting HSROC models
with fewer parameters (e.g., setting variance parameter es-
timates to zero, or assuming symmetrical SROC curves)
has been found to be a preferable approach.
We have provided empirical evidence that supports cur-
rent recommendations advocating the use of hierarchical
approaches to the statistical synthesis of test accuracy data
[30,31]. Ongoing efforts to extend the scope of the models
[32e34] and to make them more accessible [35e37] should
help to increase their uptake in future systematic reviews.
These findings raise concerns about the clinical use of
existing reviews that have used the MoseseLittenberg
approach. We have demonstrated that not only the pooled
results might be misleading, but also conclusions drawn
86 J. Dinnes et al. / Journal of Clinical Epidemiology 80 (2016) 77e87from models where covariates have been added may be un-
reliable. This finding applies not only to investigations of
heterogeneity but also to comparisons of the accuracy of
two or more tests where test covariates are added to the
models in the same way as for sources of heterogeneity.
The problem may not be considered as serious where inves-
tigations are considered exploratory but is of real concern
where comparisons between tests are made with the aim
of informing the selection of tests for use in clinical prac-
tice. Our results also potentially call into question the con-
clusions from seminal meta-epidemiology articles that have
used the MoseseLittenberg model to provide the basis for
our understanding of the biases in operation in test accuracy
studies [2,38,39].
There are a huge number of systematic reviews of diag-
nostic tests now in the public domain, many of which have
used less than optimal approaches to the synthesis of test
accuracy data. We have demonstrated the potential for
drawing misleading inferences from meta-analyses adopt-
ing the MoseseLittenberg model and recommend that
caution is used when considering their use. Our findings
support and encourage the future uptake of hierarchical
models for diagnostic test meta-analyses.Supplementary data
Supplementary data related to this article can be found at
http://dx.doi.org/10.1016/j.jclinepi.2016.07.011.References
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